| NDC Code | 51662-1564-3 |
|---|
| Package Description | 10 POUCH in 1 CASE (51662-1564-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1564-2) / 5 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 51662-1564 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Ziprasidone Mesylate |
|---|
| Non-Proprietary Name | Ziprasidone Mesylate |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20210717 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA211908 |
|---|
| Manufacturer | HF Acquisition Co LLC, DBA HealthFirst |
|---|
| Substance Name | ZIPRASIDONE MESYLATE |
|---|
| Strength | 20 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Atypical Antipsychotic [EPC] |
|---|